Tower Research Capital LLC (Trc) Novavax Inc Transaction History

Tower Research Capital LLC (Trc)

$3.29 Billion
Q1 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Novavax Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,949 shares of NVAX stock, worth $45,932. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,949

Previous 29,390 76.36%

Holding current value

$45,932

Previous $236,000 81.36%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$6.41 - $10.82 $143,846 - $242,811	-22,441 Reduced 76.36%	6,949 $44,000
Q4 2024 Feb 13, 2025	BUY	$7.22 - $14.68 $83,983 - $170,757	11,632 Added 65.5%	29,390 $236,000
Q3 2024 Nov 14, 2024	SELL	$10.71 - $17.11 $465,199 - $743,189	-43,436 Reduced 70.98%	17,758 $224,000
Q2 2024 Aug 13, 2024	BUY	$3.89 - $20.97 $231,700 - $1.25 Million	59,563 Added 3651.93%	61,194 $774,000
Q1 2024 May 15, 2024	SELL	$3.76 - $6.02 $46,296 - $74,124	-12,313 Reduced 88.3%	1,631 $7,000
Q4 2023 Feb 13, 2024	BUY	$4.8 - $7.67 $33,945 - $54,242	7,072 Added 102.91%	13,944 $66,000
Q3 2023 Nov 14, 2023	SELL	$6.81 - $9.74 $171,223 - $244,892	-25,143 Reduced 78.54%	6,872 $49,000
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $100,516 - $143,466	15,070 Added 88.93%	32,015 $237,000
Q1 2023 May 09, 2023	SELL	$5.76 - $12.48 $73,301 - $158,820	-12,726 Reduced 42.89%	16,945 $118,000
Q4 2022 Feb 10, 2023	SELL	$8.86 - $25.04 $20,005 - $56,540	-2,258 Reduced 7.07%	29,671 $305,000
Q3 2022 Nov 10, 2022	BUY	$18.2 - $76.12 $95,258 - $398,412	5,234 Added 19.61%	31,929 $581,000
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $718,452 - $1.49 Million	19,803 Added 287.33%	26,695 $1.37 Million
Q1 2022 May 12, 2022	BUY	$69.73 - $142.9 $279,896 - $573,600	4,014 Added 139.47%	6,892 $507,000
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $67,414 - $109,202	501 Added 21.08%	2,878 $412,000
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $158,419 - $241,086	891 Added 59.96%	2,377 $493,000
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $535,546 - $1.14 Million	-4,426 Reduced 74.86%	1,486 $316,000
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $143,710 - $406,950	-1,272 Reduced 17.71%	5,912 $1.07 Million
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $400,707 - $709,915	5,089 Added 242.91%	7,184 $801,000
Q3 2020 Nov 16, 2020	SELL	$79.44 - $178.51 $750,072 - $1.69 Million	-9,442 Reduced 81.84%	2,095 $227,000
Q2 2020 Aug 13, 2020	BUY	$13.86 - $83.61 $159,902 - $964,608	11,537 New	11,537 $962,000
Q1 2020 May 15, 2020	SELL	$3.93 - $16.0 $8,343 - $33,968	-2,123 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$3.69 - $5.22 $18,608 - $26,324	-5,043 Reduced 70.37%	2,123 $9,000
Q3 2019 Nov 05, 2019	BUY	$4.02 - $7.84 $23,786 - $46,389	5,917 Added 473.74%	7,166 $36,000
Q2 2019 Aug 13, 2019	BUY	$4.93 - $12.2 $6,157 - $15,237	1,249 New	1,249 $7,000

Others Institutions Holding NVAX

# of Institutions

300

Shares Held

90M

Call Options Held

5.76M

Put Options Held

6.65M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $517M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Novavax Inc Transaction History